Technical view of PfizerPfizer’s stock is moving in a short-term sideway direction.
Between levels 41 and 31.5
With high volumes.
Therefore it is possible to trade between the two levels.
4PFE trade ideas
PFE - GREAT Short Opportunity, IF ... !!Hello! Friends,
This would be a great short Opportunity, IF NYSE:PFE breaks down the Daily Support line at $37.05 (with a whole DAILY Candle) !!
$PFE Pfizer a buy above Trend-lineAfter many queries from traders on why PFE has stalled,
hopefully this simplifies the TA, its quite simple
that the downtrend and 100ma have converged to
act as strong resistance, until that breaks the stock
remains in neutral.
Indicators are in bullish reversal, so optimism is warranted.
PFIZER is taking Viagrathe stock price of Pfizer is about to overdose on viagra. Looking at the bounce from the downfall due to corona virus there is solid support from previous wave 4. With the news of Vaccines, Pfizer is promising to produce one. I am looking at a target price of $45.00
GoNoGo Charts sees positive price action for Pfizer, IncGoNoGo Charts has flagged a recent “Go” signal on Pfizer Inc, and this has driven price higher to test previous highs.
If price can consolidate above this level that would be a very good sign.
The GoNoGo Oscillator crossed into positive territory on a surge in price several bars before the “Go” flag, suggesting the trend change.
Of note now, is the heavy volume that is starting to accompany the bullish price action. This is indicated by the oscillator’s darker blue color (small grey arrow in the oscillator panel). The GoNoGo Oscillator is at an overbought extreme, but if the ensuing price pause can stay at current levels we would look for another push higher.
What are the GoNoGo Indicators?
The GoNoGo Trend indicator blends traditional trend concepts to color price action according to the strength of its trend. The colors range from *bright blue (strongly *bullish) to dark *purple (strongly *bearish)
The GoNoGo Oscillator blends traditional *momentum concepts to demonstrate the velocity of price action. The oscillator ranges from -6 (extremely *oversold) to +6 (extremely *overbought)
Looking really good on the weeklyLooking like PFE just busted a downward trend and crossing fib . Other indicators look good also.
Pfizer great news!! and resistance break!Some great vaccine news as US prepares to vaccinate the American population with 100M doses worth up to 2Billion USD and supplied by Pfizer and BioNtech!. The resistance line that PFE was under represents a long term hard resistance since 2018. PFE might go a lot higher now, perhaps as high as Moderna.
PFE LONG EARNINGS 7/28 READ HOW TO FIND A GOOD PRICEThis Earning's Season has proved nothing is every guaranteed. IBM is definitely one example although it appears to be crawling its way back up. The closer you are to a Stock's Earnings Date the bigger the difference in the bid/ask price. I bought the $36 Call using the 8/21/2020 expiration for $2.20 the bid/ask price was 2.20/2.21. You have to be patience and look for the price to turn "red" and then either bid lower and/or wait for the price to go down. I placed the trade this morning.
PFE LONG OR BUY TARGET UP TO $46Along with the good news about the PFE vaccine, it has increased the chances of success for this stock, and
if it surpasses $ 38.5, it will confirm the "Asymmetrical Triangle" pattern.
PFE buy : $38.5
PFE target : $46+-1
PFE stop loss : 10% .
Current prices are supported on all 3 averages of 25-50-200.
Wish you good deals!
PFizer D1 Global EpidemicPfizer is one of the largest pharmaceutical groups in the world. Its shares showed good growth dynamics during the quarantine period. And this is logical. During the global epidemic, medicines sold very well and the company received good income. After the quarantine restrictions were lifted, the shares sank. But recent events in the US offer new growth prospects. The epidemic in the country came out of control. Compliance with the quarantine regime during mass protests is practically impossible. The number of cases is increasing every day in the country. Pfizer is an American manufacturer and its products are very popular in this country. The current situation creates a need for the company's products. And it will be an incentive for stock growth.
Pfizer D1Pfizer shares have very good prospects for growth. After high volatility during quarantine, stocks made quite a small rollback. But the situation with the corono virus is likely to begin a new cycle. New outbreaks of disease are emerging in the United States and other developing countries. In America, the situation is generally out of control. Riots on the streets provoke an increase in people's contacts with each other. And this situation causes high disease rates. In large cities around the world, according to statistics, an increase in diseases is also noticeable. Because the company Pfizer is a manufacturer of pharmaceuticals, now you can not do without it. Moreover, this is an American manufacturer, and the United States is now the main focus of disease.
$PFE wedge $PFE - Positive news incoming and stock has been beaten down. Broke out of wedge while i was out.
PFIZER DAILY ANALYSISHi friends
the daily chart of this market shows with a strong probability of a downward trend in the coming days but we must at the same time be vigilant of reversal of this market towards the opposite direction
please subscribe for more information
$PFE Rips on Vaccine New, but has Hurdles AbovePFE shares popped higher in response to positive virus news.
The stock still has hurdles in front of it, including confluence MA resistance at $36 and critical sloped trendline pattern resistance above that in the $37.50 area.
FDA Approves BAVENCIO as First-Line Maintenance Treatment for PaPFE: Pfizer Inc.
2020-06-30 19:30:00
FDA Approves BAVENCIO as First-Line Maintenance Treatment for Patients with Locally Advanced or Metastatic Urothelial Carcinoma
@PFE - BUY based on CCI 20 Close (-76.91)BUY ONLY FOR THIS ONE...
@PFE
ESTIMATED EPS USD 0.69 - WILL BE UPDATED ON 28 JUL 2020
LAST EPS USD 0.38
LAST DIVIDEND USD 0.61
Outlook PFE / Pfizerdue to some open gaps I see some more potential in Pfizer, especially now after some successful results in their tests for a COVID-19 antidote.
